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Rationale We aimed to identify differentially methylated regions (DMRs) in cord blood DNA 
associated with childhood lung function, asthma and chronic obstructive pulmonary disease (COPD) 
across the life course.  
Methods We meta-analyzed epigenome-wide data of 1688 children from five cohorts to identify cord 
blood DMRs and their annotated genes, in relation to Forced Expiratory Volume in 1 second (FEV1), 
FEV1/Forced Vital Capacity (FVC), and Forced Expiratory Flow at 75% of FVC (FEF75) at ages 7 to 
13 years. Identified DMRs were explored for associations with childhood asthma, adult lung function 
and COPD, gene expression and involvement in biological processes.   
Results We identified 59 DMRs associated with childhood lung function, of which 18 were associated 
with childhood asthma and 9 with COPD in adulthood. Genes annotated to the top ten identified 
DMRs were HOXA5, PAOX, LINC00602, ABCA7, PER3, CLCA1, VENTX, NUDT12, PTPRN2 and 
TCL1A. Differential gene expression in blood was observed for 32 DMRs in childhood and 18 in 
adulthood. Genes related with 16 identified DMRs were associated with respiratory developmental or 
pathogenic pathways.  
Interpretation Our findings suggest that the epigenetic status of the newborn affects respiratory 





Asthma and chronic obstructive pulmonary disease (COPD) have become major global health 
problems in the last decades (1). Both diseases are characterized by airway obstruction, as indicated 
by a reduced Forced Expiratory Volume in 1 second (FEV1), FEV1 to Forced Vital Capacity (FVC) 
ratio, and Forced Expiratory Flow at 75% of FVC (FEF75) (2). Childhood lung function predicts lung 
function and risks of asthma and COPD in later life (3). An accumulating body of evidence suggests 
that asthma and COPD have at least part of their origins in fetal life (4, 5). Genetics alone fail to 
explain the quickly altering prevalence of allergies and chronic respiratory diseases in the past 
decades, because any mutation would require multiple generations to occur on a population level 
(6). Furthermore, adverse fetal exposures, such as maternal smoking and suboptimal diet, increase 
the risk of asthma and COPD (5). The pathways linking genetic predisposition and environmental 
exposures in fetal life with life course respiratory disease may include epigenetic changes, including 
DNA-methylation (5). Epigenetic changes are influenced by environmental exposures and could exert 
population effects much more rapidly than genetic mutations(6). DNA-methylation is currently the best 
understood epigenetic mechanism, and techniques have been developed to assess epigenome-wide 
DNA-methylation patterns in large population- based studies. Fetal development is characterized by 
high rates of DNA-methylation changes and rapid organ development (5). DNA-methylation may 
affect fetal development through effects on gene transcription and expression (7). Recent studies 
assessing the associations between DNA-methylation and childhood respiratory health are mainly 
limited to candidate genes and small sample sizes (3, 8). We focused on identification of differential 
DNA-methylated regions (DMRs) because regional methylation of CpGs controls cell-type-specific 
transcription. Also, the use of DMRs increases statistical power and minimizes the effects of genetic 
variants in the methylation analyses (9).  Identification of genomic regions with altered DNA-
methylation levels related to lung function and respiratory diseases across the life course is important 
to understand mechanisms underlying associations of environmental and genetic factors with the 
development of lower lung function and risk of chronic respiratory diseases. We hypothesized that 
fetal differential DNA-methylation reflected in cord blood DNA of newborns affect gene expression 
and subsequent respiratory tract development, and predispose individuals for obstructive airway 




We meta-analyzed five epigenome-wide association studies using data from 1,688 children 
participating in prospective cohort studies to identify differential DNA-methylated regions (DMRs) of 
newborns associated with childhood FEV1, FEV1/FVC and FEF75. Identified top DMRs were 
subsequently explored for their associations with childhood asthma, lung function in adolescence and 
adulthood, and COPD in adulthood, and explored for association with gene expression and 




Study Design and Data Sources 
We included population-based cohort studies participating in PACE consortium with data on 
epigenome-wide DNA-methylation at birth and lung function in childhood (12). We used data from 
1,688 Caucasian children aged 7 to 13 years participating in the Avon Longitudinal Study of Parents 
and Children (ALSPAC) (United Kingdom), Generation R (Netherlands), INfancia y Medio Ambiente 
Study (INMA) (Spain), Children’s Health Study (CHS) and Project Viva (both from the U.S.A.). These 
data were used for the primary discovery epigenome-wide meta-analysis to identify DMRs of 
newborns related to childhood lung function.  We aimed to identify DMRs instead of single CpGs 
while differences at any individual CpG may be small, and the use of DMRS might minimize the 
effects of genetic variants in the methylation analysis (13, 14).  
We used several resources for the secondary analyses. For clinical outcomes, we used childhood 
asthma data (Generation R, mean age 6 years), lung function data from adolescents (ALSPAC, mean 
age 15 years) and adults (Rotterdam Study, mean age 66 years, The Netherlands), and COPD data 
in adults (Rotterdam Study) (Figure 1). For gene expression, we used blood samples from children 
(INMA, at birth and mean age 4 years) and adults (Rotterdam Study). Last, we used publicly available 
resources to relate identified DMRs with biological processes (15-17). Parents, legal representatives 
or participants provided informed consent in accordance with local ethics policies. Detailed 






All cohorts extracted DNA from blood samples and used the EZ-96 DNA Methylation kit (Zymo 
Research Corporation, Irvine, USA) for bisulfite conversion. Samples were processed with the 
Infinium HumanMethylation450 BeadChip (Illumina Inc., San Diego, USA) followed by cohort-specific 
quality control, probe exclusion and data normalization. Detailed information on cohort-specific data 
acquisition and quality control is provided in the Supplementary Appendix. 
 
Respiratory Outcome Assessment 
Lung function measures comprised pre-bronchodilator FEV1, FEV1/FVC and FEF75, which were 
converted into sex-, age-, height- and ethnicity-adjusted z-scores (18). Physician-diagnosed asthma 
was obtained by questions adapted from the International Study on Asthma and Allergy in Childhood 




Primary Meta-analysis on Childhood Lung Function A detailed description of applied methods is 
presented in the Supplementary Appendix. Individual cohorts used robust linear regression models 
to examine the associations of DNA-methylation levels of CpGs with childhood FEV1, FEV1/FVC and 
FEF75. Analyses were adjusted for maternal age, socio-economic status, smoking during pregnancy, 
parity, asthma or atopy, technical covariates and estimated cell counts (21). Results were combined 
using inverse variance-weighted fixed-effect meta-analyses. Results from unadjusted models were 
similar to fully adjusted models (Supplementary Appendix Table 1). Using p-values obtained from 
the meta-analyses, we identified DMRs using the software-tool Comb-p, which is the most robust tool 
to identify DMRs with small effect sizes (9, 22).  Regions were defined as a minimum of 2 probes 
within a window size of 500 bases with an FDR-threshold <0.05 (9). Comb-p uses unadjusted p-
values for each probe as input, and calculates adjusted p-values for each probe that account for the 
correlation with nearby CpGs (23). Next, the SLK p-values were adjusted for multiple testing and 
adjusted into q-values. Comb-p finds DMRs based on these q-values and calculates p-values for 
these DMRs based on the original p-values. Finally, the DMR p-values were adjusted for multiple 
testing using the Šidák-correction based on the size of the region and number of possible regions of 




(theoretically) does not have a maximum number of windows and DMRs. A more extensive 
description of the identification of DMRS is provided in the Supplementary Material. Annotation of the 
genes located nearest to the DMRs was performed using Peak Annotation and Visualization (PAVIS) 
(24). We limited annotation to a region of 500kb (250kb upstream, 250kb downstream of the 
beginning and end of the region, respectively). All annotations were based on human GRCh37/hg19 
assembly. Because genetic variants in Infinium probes could result in spurious methylation 
measurements, we performed a sensitivity analysis in a subset of high-quality probes (n=294,834) 
without SNPs, insertions or deletions, repeats, polymorphic probes and bisulfite induced reduced 
genomic complexity (25). 
Secondary Analyses on Later Life Lung Function and Respiratory Diseases We used linear and 
logistic regression models to examine the associations of CpGs within identified DMRs with asthma in 
childhood, FEV1, FEV1/FVC and FEF75 in adolescence and adulthood, and COPD in adulthood. 
Single CpG p-values were used to reconstruct the identified DMRs with Comb-p, applying identical 
parameter settings as in the discovery meta-analyses including false discovery rate (FDR)-correction 
(9, 26). We did not apply Šidák-correction because analyses were limited to the identified DMRs.  
Gene Expression Analyses We assessed the associations of CpGs within identified DMRs with 
gene expression in a region of ±250kb in blood samples from children and adults. P-values of CpGs 
associated with gene expression were combined for each DMR using a modified generalized Fisher 
method and FDR-correction (26, 27). Additionally, we explored whether the annotated and 
differentially expressed genes were expressed in human lung specimens of the Genotype-Tissue 
Expression (GTEx) database (15). 
Exploration biological processes The Gene Ontology database implemented in DAVID and 
Genemania was used to examine gene function in biological processes (16, 17). We examined 
pathways for all genes annotated to the DMRs and for genes with differential expression in 
association with the identified DMRs. We used the Kyoto Encyclopedia of Genes and Genomes 
(KEGG) database in DAVID and Genemania, the OMIM database and the Universal Protein 
Resource (UniProt) to explore whether annotated or expressed genes have been related to 
respiratory development or diseases (28). We used the Ensemble Genome browser to visualize the 








Meta-analysis of Epigenome-wide Association Studies on Childhood Lung Function  
Characteristics of the participating cohorts are given in Table 1 and Supplementary Appendix Table 
2.  
We identified 22, 15 and 22 DMRs associated with FEV1, FEV1/FVC and FEF75, respectively (Figure 
2, Supplementary Appendix Tables 3 and 4). A higher mean methylation of CpGs located within 37 
(63%) of the identified DMRs was associated with higher lung function measures, and within 22 (37%) 
of identified DMRs with lower lung function measures. We observed a high homogeneity across the 
included studies (CpGs with I2 <50: FEV1 140/163 (86%), FEV1/FVC 82/89 (92%) and FEF75 139/148 
(87%)) (Supplemental Tables 4a-c). 
Of the top ten significant DMRs associated with childhood lung function, the 5 DMRs and their 
annotated genes for FEV1 were located at chr7:27,183,133-27,184,854 (HOXA5), chr10:135,202,522-
135,203,201 (PAOX), chr6:166,418,799-166,419,139 (LINC00602), chr19:1,063,624-1,064,219 
(ABCA7) and chr1:7,887,199-7,887,561 (PER3).  Three DMRs and their annotated genes for 
FEV1/FVC were located at chr1:86,968,087-86,968,544 (CLCA1), chr10:135,051,149-135,051,582 
(VENTX), and chr5:102,898,223-102,898,734 (NUDT12).  Two DMRs for FEF75 and their annotated 
genes were located at chr7:158,045,980-158,046,359 (PTPRN2) and chr14:96,180,406-96,181,045 
(TCL1A). After exclusion of potentially problematic probes containing genomic variants, 41 of the 59 
previously identified DMRs still contained ≥2 CpGs (supplementary appendix Table 4). Of these 41 
41 DMRs, 54% (n=22) remained to be associated with childhood lung function  (Supplementary 
appendix Table 5). 
 
Identified DMRs and Lung Function and Respiratory Diseases Across the Life Course 
Of all 59 identified DMRs related with childhood lung function, 18 (31%) were associated with 
childhood asthma (Figure 3, Supplementary appendix Table 6). Furthermore, 11 (19%) and 9 
(15%) DMRs were associated with lung function in adolescence and adulthood, respectively, and 9 
(15%) were associated with COPD. The DMRs annotated to HOXA5 and PAOX were associated with 




The DMRs annotated to PER3 and VENTX were associated with childhood and adolescence FEV1 
and FEV1/FVC, respectively. The DMR annotated to NUDT12 was associated with childhood 
FEV1/FVC and COPD. The DMRs annotated to PTPRN2 and TCL1A were associated with childhood 
FEF75 and asthma. The DMRs annotated to LINC00602, ABCA7 and CLCA1 were associated with 
childhood lung function but not with other outcomes.  
 
Identified DMRs and Gene Expression 
Of the 59 identified DMRs, 32 (54%) DMRs at birth were associated with gene expression at age 4 
years, and 18 (31%) DMRs with gene expression in adulthood (Supplementary Appendix Table 7). 
The DMR annotated to HOXA5 was associated with differential expression of several genes of the 
HOX-family (Table 2). The DMRs annotated to PER3, VENTX , NUDT12 and TCL1A were associated 
with differential expression of their respective genes. The DMRs annotated to PAOX, LINC00602, 
ABCA7, CLCA1 and PTPRN2 were not associated with expression of their corresponding genes. 
Genes annotated to 28 (47%) of all identified DMRs were expressed in adult lung tissue, including the 
top significant DMRs annotated to PAOX, ABCA7, CLCA1, VENTX and NUDT12 (Supplementary 
Appendix Table 8).  
 
Identified DMRs and related biological processes  
Of all 59 identified DMRs, 43 were annotated to genes not previously associated with lung function or 
respiratory morbidity (Supplementary Appendix Table 7). Of the genes annotated to the top ten 
significant DMRs, HOXA5, CLCA1, TCL1A and NUDT12 were previously associated with respiratory 
development including alveogenesis, respiratory diseases and cellular immunity (Table 2). Genes 
related to the identified DMRs, including HOXA5, PER3, CLCA1, NUDT12 and PTPRN2, were 
located in pathways related to regionalization, DNA- and RNA-regulation and embryonic development 
(Supplementary Appendix Tables 9). The genes HLA-DRB4 and HLA-DRB5 were enriched in 
processes including asthma. These genes were associated with the DMR located at chr6:32,305,068-
32,305,146, which was related with childhood and adulthood FEV1/FVC and COPD.  
Of the top ten significant DMRs, the DMRs annotated to HOXA5, CLCA1 and TCL1A contained 




NUDT12 were located in promotor regions of their respective genes. The DMR annotated to ABCA7 
was located in a CpG-island.  
 
DISCUSSION 
We identified 59 DMRs in neonatal cord blood associated with childhood lung function. Eighteen 
(31%) of all identified DMRs were also associated with childhood asthma, 11 (19%) and 9 (15%) with 
adolescent and adult lung function, respectively, and 9 (15%) with COPD. Differential gene 
expression was observed for 32 (54%) DMRs in childhood and 18 (31%) DMRs in adulthood. Multiple 
genes related to the identified DMRs have previously been associated with respiratory development 
and morbidity, and many identified DMRs were located within known regulatory elements for gene 
expression.  
Reduced lung function in childhood is associated with reduced lung function and increased risks of 
asthma and COPD many decades later (10, 29). Pathways of environmental exposures in early life, 
such as tobacco smoke exposure or lack of breastfeeding, that affect lung development and risk of 
chronic obstructive respiratory diseases in later life might be modified by genetic susceptibility. Vice 
versa, genetic susceptibility could partly explain the difference in adverse effects of early 
environmental exposures on the risk of chronic obstructive respiratory diseases in later life. Identified 
genetic variants associated with childhood asthma in large-scale GWA studies only account for up to 
7.5% of the explained variance (30). Epigenetic mechanisms could link environmental exposures with 
the unexplained heritability for childhood asthma (31, 32). Studies that examined associations of 
DNA-methylation with lung function, asthma or COPD are scarce, limited to candidate genes or high-
risk population and lack replication. An epigenome-wide study among 97 asthmatics and 97 healthy 
children aged 6-12 years identified 81 DMRs associated with asthma, of which 16 DMRs were also 
associated with FEV1 (8). Of these 81 DMRs, 19 were located within 500kb of our identified DMRs 
and may affect the same genes. Another epigenome-wide study in 1,454 adults identified 349 CpGs 
associated with COPD (33). Four annotated genes in this adult study (CBFA2T3, PADI4, LST1, 
KCNQ1) were replicated in our study of children. Multiple genes associated with the identified DMRs 
have previously been related with asthma and COPD in genome-wide association studies. TCL1A 
has been identified as asthma-susceptibility gene (34). Nine (15%) of the 59 DMRs we identified were 




genes. Nine of these genes were previously linked with pulmonary structures (CROCC, CLCA1), 
immunity (MARCKS, FOXD2, MEF2C, CMBL, CLCA1), asthma (MARCKS, HCG23, CLCA1), COPD 
(MARCKS, TBX5, CLCA1), and smoking behavior in COPD (NUDT12) (28). This suggests that genes 
associated with respiratory diseases could be influenced by differential DNA-methylation from early 
life onwards.  
We explored the biological processes of the top significant DMRs for development of respiratory 
morbidity (28). The DMR annotated to HOXA5 was associated with childhood and adolescent FEV1, 
COPD and differential expression of HOXA1, HOXA4 and HOXA7. One DMR associated with 
childhood FEV1/FVC was annotated to VENTX, which is a member of the HOX-gene family. The DMR 
annotated to LINC00602 (Long Intergenic Non-Protein Coding RNA (lncRNA) 602) was linked to 
childhood FEV1. LncRNAs influence gene-specific epigenetic regulation and interact amongst others 
with the transcription of HOX-genes. HOX-genes are critical for segmental fetal development, and 
especially HOXA5 is required for embryonic respiratory tract morphogenesis (35, 36). The DMR 
annotated to PAOX was linked to childhood and adolescence FEV1 and COPD. PAOX is involved in 
the regulation of intracellular polyamine, which is essential for protein synthesis. The DMR linked to 
ABCA7 was associated with FEV1 in childhood and adolescence. ABCA7 is involved in the lipid 
homeostasis in the cellular immune system and is essential for phagocytosis of apoptotic cells by 
alveolar macrophages (37). PER3, annotated to a DMR associated with FEV1 in children and 
adolescents, is a key element in the endogenous circadian rhythm. The DMR linked to CLCA1 was 
associated with childhood FEV1/FVC and FEF75, and expressed in adult lung tissue. CLCA1 affects 
IL-13 driven mucus production in human airway epithelial cells and is associated with asthma and 
COPD (38-40). NUDT12, annotated to a DMR associated with childhood FEV1/FVC and COPD, is 
involved in intracellular biochemical reactions. NUDT12 is associated with smoking behavior in COPD 
(41).  
PTPRN2, annotated to a DMR associated with childhood FEF75 and asthma is member of a gene 
family regulating cell growth and differentiation, and is involved in vesicle-mediated secretory 
processes. DNA-methylation of PTPRN2 differentiates between lung cancer, pulmonary fibrosis and 
COPD (42). TCL1A, annotated to a DMR associated with childhood FEV1/FVC, FEF75 and asthma, is 




of the genes annotated to the top significant DMRs are involved in respiratory development, cellular 
immunity and respiratory morbidity, which warrant further studies.  
This is the largest study to date evaluating the associations of newborn epigenome-wide DNA-
methylation with lung function and respiratory disease in children and adults, and it provides new 
insights into the epigenetic changes in fetal life that increase the risk of life-time respiratory morbidity. 
To the best of our knowledge, no other cohort studies with data on cord blood DNA-methylation and 
childhood lung function are available. We aimed to strengthen our results using public databases on 
gene expression and biological pathways, which added additional support for the observed 
associations. Ideally, the presence of identified DMRs would be replicated in lung cells. However, in 
cohort studies, this is ethically not done. It is unknown whether nasal cells, which are easier to 
acquire, have a high enough correlation in DNA-methylation with lung tissue. Therefore, further 
studies should aim to examine whether DNA-methylation in nasal cells is a good proxy for lung tissue 
and data on DNA-methylation and phenotypes should be shared in consortia to increase the statistical 
power to identify DNA-methylation patterns affecting respiratory health across the life course. These 
results cannot currently be used as predictors of disease in individuals, but are important from an 
etiological perspective. Genes associated with 29 of the identified DMRs, including HOXA5, PAOX, 
VENTX, PTPRN2 and TCL1A, have been reported to be differentially methylated in relation with 
maternal smoking during pregnancy (12). Genes related with four identified DMRs associated with 
childhood lung function were differentially methylated in association with maternal folate levels during 
pregnancy (43). This supports the hypothesis that adverse exposures in fetal life may impact DNA-
methylation at birth, gene expression and subsequent respiratory development in the child, 
predisposing individuals for obstructive airway diseases. Further experimental or Mendelian 
randomization studies on the identified DMRs and associated genes might inform strategies in early 
life to improve lung function and lower the lifetime risk of obstructive respiratory diseases. 
Some limitations should be discussed. We measured DNA-methylation in blood because it is easily 
accessible in large cohort studies. Blood DNA-methylation does not necessarily reflect lung epithelial 
DNA-methylation. However, asthma and COPD have systemic manifestations, characterized by 
increased inflammatory blood markers (44, 45). Although the analyses were adjusted for estimated 
cell counts, we cannot rule out residual confounding due to alterations in cell type distribution. 




47). These reference sets are currently being validated, and future studies will shed light on the 
differences between reference panels. In our secondary analyses, we assessed whether the identified 
DMRs were associated with lung function measured in adolescence and adulthood, similar to the 
associations identified between cord blood DNA methylation and childhood lung function. DNA 
methylation patterns and expression of genes vary depending on the developmental stage, and these 
changes could be non-linear (48). We were not able to assess the stability of DNA methylation in the 
identified DMRs in the same individuals from birth to adulthood. In a recent study addressing DNA 
methylation changes in early life, significantly reduced or increased methylation of single CpGs 
between ages 0 to 4 years and 4 to 8 years occurred in <4% of all CpGs, suggesting only a minor 
global change in DNA methylation in childhood (49). Longitudinal changes in DNA methylation from 
early life until adulthood in relation to respiratory morbidity have not been studied yet. We observed 
similar associations between DNA methylation of a specific genetic region with lung function, asthma 
or COPD observed in early life and adulthood, and this strengthens our hypothesis that specific DNA 
methylation patterns affect respiratory health across the life course. Further studies in longitudinal 
cohort studies with repeated measures of DNA methylation from birth into adulthood in the same 
individuals are needed to confirm this.  
We presented our primary results including all probes, and provided results of analyses excluding 
potentially problematic probes, namely those with SNPs, insertions or deletions, repeats and bisulfite 
induced reduced genomic complexity. These underlying variants may affect probe binding and as 
such, affect the identified associations. In our stringent sensitivity analyses, we observed similar size 
and direction of the effect estimates in 54% of the identified DMRs associated with childhood lung 
function. However, the true exact impact of potentially problematic probes on the measurement of 
DNA methylation in our analyses remains unknown (25, 50). Discarding probes a priori may discard 
information. Therefore, we present all results of the main and sensitivity analysis.  
Genetic variation as opposed to environmental variation might be influencing the DMRs associated 
with respiratory health. A recent study in two ethnic diverse adult cohorts in 557 subjects showed that 
DNA methylation of airway epithelium plays a central role in mediating the effects of SNPs and gene 
expression on asthma risk and its clinical course (51). Another study in 115 subjects participating in 
an adult cohort study reported a potential mediating effect of DNA methylation of single CpGs on the 




identified 6 CpGs associated with gene expression of ORMDL3 and GSDMB. The authors did not 
assess the associations of DNA methylation with asthma or lung function. We did not identify any 
DMR located near the 17q21 locus. This could be explained by the young age of our study subjects or 
differences in main respiratory outcomes measurements. The previous studies stepwise assessed the 
effect of DNA methylation with the gene expression, and associations of SNPs with asthma, whereas 
our study focused on the direct associations between DNA methylation and respiratory outcomes. 
Further research is needed to assess this potential biological pathway.  
Several identified DMRs were associated with gene expression other than the nearest and therefore 
annotated gene, which limits the potential biological effect of the annotated genes. The genomic 
inflation factor for the primary analyses ranged from 1.07 to 1.21 (Supplementary Figure 1). 
Recently, it was shown that the genomic inflation factor provides an invalid estimate of test-statistic 
inflation when the outcome of interest is associated with many, small genetic effects (53). 
Furthermore, estimating the inflation factor using the genomic inflation factor results both in an 
overestimation of the actual inflation and in imprecise estimates contributing to the previously 
unexplained, high variability across studies. This might explain the genomic inflation in our analyses. 
The statistical steps in Comb-P limit the final number of DMRs identified, and genomic inflation in the 
identification of DMRs could not be tested. Further studies are needed to develop statistical tools 
dealing with genomic inflation in epigenome-wide studies. 
There were no cohort studies available for replication analyses. We included all available cohorts in 
the meta-analysis to obtain the largest possible power to detect new associations. A previously 
published study has shown that in (epi)genome-wide association analyses a meta-analysis of all 
participating cohorts rather than a split sample analysis with a properly selected level of (epi)genome-
wide significance is the most powerful approach to identify new associations (54). The high between-
study homogeneity observed for the vast majority of CpGs in our meta-analysis (Supplementary 
Tables 4a-c) also provides support for the stability of the reported associations. Nevertheless, 
confirmatory studies are needed. 
In conclusion, we identified 59 DMRs in cord blood that were associated with childhood lung function. 
Multiple DMRs were additionally related with childhood asthma, adolescent and adult lung function, or 
adult COPD. Also, multiple DMRs were associated with differential gene expression of genes involved 




expression. These findings suggest that epigenetic changes during fetal life might modify the risk of 
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 No. of 
participants 






No. of subjects 
with expression 
data 






     Years (SD) Cases Controls Cases Controls 
Primary analyses          
ALSPAC (UK)  654 Cord blood 471,193 n.a. 8·6 (0·2) n.a. n.a. n.a. n.a. 
Generation R (NL) 643 Cord blood 436,013 n.a. 9·8 (0·3) 47 663 n.a. n.a. 
INMA (Spain) 140 Cord blood 439,306 107 6·9 (0·3) n.a. n.a. n.a. n.a. 
CHS (USA) 75 Cord blood 383,857 n.a. 13·3 (0·6) n.a. n.a. n.a. n.a. 
Project Viva (USA) 176 Cord blood 470,870 n.a. 7·9 (0·7) n.a. n.a. n.a. n.a. 




ALSPAC (UK) 542 Cord blood n.a. n.a. 15·4 (0·2) n.a. n.a. n.a. n.a. 
Rotterdam Study – I (NL) 488 Peripheral blood n.a. 488 64·0 (6·3) n.a. n.a. 63 425 
Rotterdam Study – II (NL) 703 Peripheral blood n.a. 703 67·5 (5·9) n.a. n.a. 92 611 
 
Lung function was obtained by spirometry and sex-, age-, height- and ethnicity-adjusted Z-scores were calculated. FEV1: Forced Expiratory Volume in 1 
second; FVC: Forced Vital Capacity; FEF75: Forced Expiratory Flow at 75% of FVC; n.a.: not applicable. UK: United Kingdom. NL: the Netherlands. USA: 






Table 2. Associations of the Top Ten Significant Identified Differentially Methylated Regions with Gene Expression and Related Respiratory Outcomes.  
Molecular location of the 
differentially methylated region 









in children‡  
Gene 
expression 
in adults§  
Previously associated with lung 
development or respiratory 
morbidity‖ 
chr1: 7,887,199 - 7,887,561 FEV1 PER3 PER3, RP3-467l1.4,  RNA5SP23,  RP4-726F1.1 ↓ -  
   RP11-431K24.1 - ↑  
chr1: 86,968,087 – 86,968,544 FEV1/FVC CLCA1 no expression - - Lung development, asthma, 
COPD 
chr5: 102,898,223 - 102,898,734 FEV1/FVC NUDT12 NUDT12 ↓ - Smoking behavior in COPD  
   CMBL ↓ -  
chr6: 166,418,799 – 166,419,139 FEV1 LINC00602 no expression - -  
chr7: 27,183,133 - 27,184,854 FEV1 HOXA5 HOXA1, HOTTIP ↓ ↓ Lung development, FEV1, 
FEV1/FVC 
   EVX1, HOXA4, HOXA7 ↓ - Lung development, asthma, 
COPD 
chr7: 158,045,980 – 158,046,359 FEF75 PTPRN2 no expression - -  
chr10: 135,202,522 – 
135,203,201 
FEV1 PAOX no expression - -  





   VENTX,  ECHS1 ↑ -  
   SPRN ↑ ↓  
   ZNF511 - ↑  
chr14: 96,180,406 – 96,181,045 FEF75 TCL1A TCL1A,  CCDC85C ↓ - Asthma 
chr19: 1,063,624 – 1,064,219 FEV1 ABCA7 no expression - -  
Results present identified differentially methylated regions (DMRs) from association-analyses of DNA-methylation at birth with childhood Forced Expiratory 
Volume in 1 second (FEV1), FEV1/ Forced Vital Capacity (FVC) and Forced Expiratory Flow at 75% of FVC (FEF75). *DMRs were annotated to their nearest 
gene. †: Identified DMRs at birth were associated with gene expression in: ‡: childhood (INMA; mean age 4 years) and §: adulthood (the Rotterdam Study, 
mean age 66 years). Gene expressions levels were assessed limited to 250kb up- and downstream of the outer border of the DMR. Directions of associations 
are marked ↓ if a higher methylation of the DMR was associated with a decreased expression of the specific gene, ↑ if a higher methylation of the DMR was 
associated with an increased expression of the specific gene, and - if no direction of associations were observed. ‖: Associations of expressed genes with 




Figure 1. Overall Study Design. 
 
Epigenome-wide meta-analyses were performed to identify methylated CpGs associated with lung function in children using data from 1,689 children 
participating in ALSPAC, Generation R, INMA, CHS and Project Viva. Identified differentially methylated regions (DMRs) were annotated to their nearest gene 
using PAVIS. Next, we examined if identified DMRs were associated with asthma in children participating in Generation R, lung function in adolescents and 
adults participating in the ALSPAC or Rotterdam Study, or COPD in adults participating in Rotterdam Study, and with gene expression levels in children 
participating in INMA, adults in Rotterdam Study, and the GTEx-database. We further explored biological processes and associations with lung development 
and respiratory morbidity using publicly available resources (DAVID, GeneMania, OMIM and UniProt). N = x: number of participants included for the analysis. 




Figure 2. Manhattan Plots of Associations of CpGs located in Differentially Methylated Regions with 
Childhood Lung Function Outcomes.  
 
Green dots represent p-values from associations of CpGs located in differentially methylated regions 
(DMRs) at birth with childhood Forced Expiratory Volume in 1 second (FEV1), FEV1/ Forced Vital 
Capacity (FVC) and Forced Expiratory Flow at 75% of FVC (FEF75). P-values of DMRs ranged from 
3·05E-14 to 0·031, and details are provided in Supplementary Appendix Table 3. Nearest annotated 
genes of DMRs are provided. The genes annotated to the top ten significant DMRs associated with 
childhood lung function are written in red. Single CpGs are presented as red and blue dots, corrected 







Figure 3. Identified Differentially Methylated Regions and Their Location, and Direction of 
Associations with Childhood Lung Function, Childhood Asthma, Adolescent Lung Function, and Adult 
Lung Function and COPD. 
 
Results present identified differentially methylated regions (DMRs) from association-analyses of DNA-
methylation at birth with childhood Forced Expiratory Volume in 1 second (FEV1), FEV1/ Forced Vital 
Capacity (FVC) and Forced Expiratory Flow at 75% of FVC (FEF75), their location, and their direction 
of association with childhood lung function, childhood asthma, adolescent lung function, and adult 
lung function and COPD. Molecular locations of the top ten significant DMRs are presented in bold. 
Identified DMRs associated with childhood lung function and other respiratory outcomes are marked 
in grey, and if not associated with respiratory outcomes in white. Directions of associations are 
marked ↓ if a higher mean methylation of the DMRs was associated with a lower z-score for lung 
function or lower risk of asthma or COPD, and marked ↑ if a higher mean methylation of the DMRs 
was associated with a higher z-score of lung function or higher risk of asthma or COPD. Red colored 
arrows represent disadvantageous effect estimates (lower lung function, increased risk of asthma or 
COPD), and green colored arrows beneficial effect estimates (higher lung function, lower risk of 
asthma or COPD). 
 
 
 
 
 
 
